Skip to Content

'
Victor Lavis, M.D.

Present Title & Affiliation

Primary Appointment

Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Clinical Interests

For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:

Contact Information

Education & Training

Degree-Granting Education

1962 Stanford University, Stanford, CA, MD, Internal Medicine
1959 Stanford University, Stanford, CA, AB, with great distinction, Biological Sciences

Postgraduate Training

1969-1971 Trainee of Research Training Unit, University of Washington School of Medicine, Seattle, WA, Seymour Klebanoff, MD
1969-1970 Special Fellow of NIH, Endocrinology, University of Washington School of Medicine, Seattle, WA, Robert H. Williams, MD
1967-1969 Postdoctoral Fellow, University of Washington School of Medicine, Seattle, WA, Robert H. Williams, MD
1966-1967 Resident, Internal Medicine, UCLA School of Medicine, Los Angeles, CA, William N. Valentine, MD
1962-1964 Intern and Assistant resident, Internal Medicine, Harvard Medical Service, Boston City Hospital, Boston, MA, Charles S. Davidson, M.D.

Board Certifications

12/2008 American Board of Internal Medicine, Endocrinology and Metabolism
1969 American Board of Internal Medicine

Selected Publications

Peer-Reviewed Original Research Articles

1. Leichman JG, Lavis VR, Aguilar D, Wilson CR, Taegtmeyer H. The metabolic syndrome and the heart; a considered opinion. Clin Res Cardiol 95(supplement1):i134-i141, 2006. PMID: 16598541.
2. Picolos MK, Lavis VR, Orlander PR. Milk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients. Clin Endocrinol (Oxf) 63(5):566-76, 11/2005. PMID: 16268810.
3. Rodriguez T, Lavis VR, Meininger JC, Kapadia AS, Stafford LF. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 11(4)(4):223-33, Jul-Aug, 1/2005. PMCID: PMC1455482.
4. Picolos MK, Sims CR, Mastrobattista JM, Carroll MA, Lavis VR. Milk-alkali syndrome in pregnancy. Obstet Gynecol 104(5 Pt 2):1201-4, 8/2004. PMID: 15516453.
5. El-Muayed M, Lavis VR, Safi HJ, Fuentes F. Use of glitazones in cardiac patients; a case for B-type natriuretic peptide monitoring? Am J Cardiol 93(5):600-602, 7/2004. PMID: 14996586.
6. Boccalandro C, De Mattia F, Guo DC, Xue L, Orlander P, King TM, Gupta P, Deen PM, Lavis VR, Milewicz DM. Characterization of an aquaporin-2 water channel gene mutation causing partial nephrogenic diabetes insipidus in a Mexican family: evidence of increased frequency of the mutation in the town of origin. J Am Soc Nephrol 15(5)(5):1223-31, 6/2004. PMID: 15100362.
7. Boccalandro, C., Lopez, L., Boccalandro, F., and Lavis, V.;. Electrocardiographic changes in thyrotoxic periodic paralysis. Analysis of 6 cases. Am. J. Cardiol. 91(6):775-777, 2003.
8. Boccalandro, C., Lopez-Penabad, L., Boccalandro, F., andLavis, V.;. Ventricular fibrillation in a young Asian man. Lancet 361(9367):1432, 2003.
9. Brod SA, Atkinson M, Lavis VR, Brosnan PG, Hardin DS, Orlander PR, Nguyen M, Riley WJ. Ingested IFN-alpha preserves residual beta cell function in Type 1 diabetes. J Interferon Cytokine Res 21(12):1021-1030, 2001. PMID: 11798459.
10. Lavis VR, D'Souza D, Brown SD. Decompensated diabetes. New features of an old problem. Circulation 90(6):3108-12, 12/1994. PMID: 7994861.
11. Lowry PA, Semenkovich JW, Scott LD, Zeck OF, Desai A, Lavis VR. Administration of 131 I capsule via nasogastric tube in an uncooperative patient with Graves disease. AJR Am J Roentgenol 155(3)(3):611-612, 1990. PMID: 2117363.
12. Lavis VR, Lee DP, Shenolikar S. Evidence that forskolin binds to the glucose transporter of human erythrocytes. J Biol Chem 262(30):14571-5, 10/1987. PMID: 3667590.
13. Lavis VR, Davenport R, Pontier P, Thompson WJ, Strada SJ. Cyclic AMP does not modulate hexose uptake of serum-deprived BHK-21 fibroblasts. J Cell Physiol 112(3):373-375, 1982. PMID: 6182151.
14. Thompson WJ, Ross CP, Strada SJ, Hersh EM, Lavis VR. Comparative analyses of cyclic adenosine 3':5'-monophosphate phosphodiesterases of human peripheral blood monocytes and cultured P388D1 cells. Cancer Res 40(6):1955-60, 6/1980. PMID: 6154534.
15. Lavis VR, Thompson WJ, Strada SJ. Effects of insulin on glycogen metabolism of serum-deprived BHK-21 fibroblasts. J Cell Physiol 103(1):55-62, 1/1980. PMID: 6253506.
16. Lavis VR, Strada SJ, Ross CP, Hersh EM, Thompson WJ. Comparison of the responses of freshly isolated and cultured human monocytes and P388D1 cells to agents affecting cyclic AMP metabolism. J Lab Clin Med 96(3):551-562, 1980. PMID: 6156975.
17. Ross JB, Rousslang KW, de Han C, Lavis VR, Deranleau DA. [12-Homoarginine]glucagon: synthesis and observations on conformation, biological activity, and copper-mediated peptide cleavage. Biochim Biophys Acta 576(2):372-84, 2/1979. PMID: 427194.
18. Lavis VR. Hexokinase isozymes of normal human subcutaneous adipose tissue. Metabolism 27(9):1101-1108, 1978. PMID: 682973.
19. Lavis VR, Williams RH. Comparison of the lipolytic effects of insulin and proinsulin on isolated fat cells. Diabetes 24(2):238-239, 1975. PMID: 1123111.
20. Thompson WJ, Johnson DG, Lavis VR, Williams RH. Effects of secretin on guanyl cyclase of various tissues. Endocrinology 94(1):276-278, 1/1974. PMID: 4148764.
21. Sakai T, Thompson WJ, Lavis VR, Williams RH. Cyclic nucleotide phosphodiesterase activities from isolated fat cells. Correlation of subcellular distribution with effects of nucleotides and insulin. Arch Biochem Biophys 162(2):331-339, 1974. PMID: 4366367.
22. Sakai T, Lavis VR, Ensinck JW, Williams RH. Effects of extracellular proteases on incorporation of amino acids into protein by isolated rat tissues. Proc Soc Exp Biol Med 145(3):1096-1099, 1974. PMID: 4206513.
23. Lavis, V.R. and Williams, R.H.. The lipolytic effects of high concentrations of insulin on isolated fat cells Enhancement of the response to lipolytic hormones. Diabetes 22:629-636, 1/1973.
24. Sakai, T., Lavis, V.R. and Williams, R.H.;. Incorporation of leucine into protein by isolated fat cells; Effects of agents which stimulate glucose metabolism and inhibit lipolysis. Biochem. Pharmacol. 22:2761-2762, 1973.
25. Sakai T, Lavis VR, Williams RH. Treatment of isolated fat cells with trypsin inhibits the effects of insulin on incorporation of leucine into protein. Diabetologia 9(5):422-425, 1973. PMID: 4773202.
26. Lavis VR, Ensinck JW, Williams RH. Effects of insulin and proinsulin on isolated fat cells and hemidiaphragms from rats. Endocrinology 87(1):135-42, 7/1970. PMID: 5445361.
27. Lavis VR, Williams RH. Studies of the insulin-like actions of thiols upon isolated fat cells. J Biol Chem 245(1):23-31, 1970. PMID: 5411544.
28. Lavis, V.R., Kitabchi, A.E. and WIlliams, R.H. In Vitro lipid peroxidation in isolated fat cells of rats: Correlation with total lipolysis, glucose utilization, and dietary tocopherol. J. Biol. Chem. 244(16):4382-4386, 8/1969.
29. Kalman, S.M., Lombrozo, M.E. and Lavis, V.R. Effect of estradiol on the transfer rate of small molecules into the rat uterus. Science 134:1272, 1961.

Abstracts

1. Crawford K, Levesque C, Brady V, Owens A, Busaidy N, Lavis V. Glycemic management of hospitalized patients receiving tube feeding in a cancer center. Abstract 19-196. Abstracts of the 2008 International MASCC/ISOO Symposium, 2008.
2. Brady V, Crawford KM, Levesque C, Owens A, Busaidy N, Lavis V. Increased Insulin Requirements in Patiens with Diabetes Receiving Hyper-CVAD. American Association of Diabetes Educators National Meeting. Washington, DC August,, 2008.
3. Brady V, Crawford K, Levesque C, Owens A, Lavis V. Busaidy N. Increased insulin requirements in patients with diabetes receiving hyper-CVad. Abstract 24-254. Abstracts of the 2008 International MASCC/ISOO Symposium, 2008.
4. Crawford KM, Levesque C, Brady V, Owens A, Busaidy N, Lavis V. Increased Insulin Requirements in Patients with Diabetes Receiving Tube Feeding. American Association of Diabetes Educators National Meeting. Washington, DC. August, 2008.
5. Shah P, Cui J,Busaidy NL,Sherman SI, Lavis VR. Why is "new" hyperglycemia dangerous in the cancer hospital?. Program of 68th Annual Meeting of The American Diabetes Association, 2008.
6. Vu K, Lavis V, Strom S, Faderl S, Konopleva M, Thomas D, Gruschkus J, Hubbard M, Andreeff M, Kantarjian H. Hyperglycemia and obesity in patients (pts) with acute lymphoblastic leukemia (ALL): association with prevalence, response, and survival. Program of The American Society for Clinical Oncology, 6/2007.
7. Kapoor S, Cui J, Busaidy N, Lavis V, Shah P. Recognized and unrecognized hyperglycemia in cancer inpatients. Program of The American Society for Clinical Oncology, 6/2007.
8. Boccalandro C, Rivera-Davila M, Nelson SC, Palacios GA, Lavis VR. Extreme insulin resistance induced by total parenteral nutrition in a woman with diabetes, HIV lipodystrophy and a kidney transplant. Program of 89th Annual Meeting of The Endocrine Society, 2007.
9. Prasad A, Eng C, Shah P, Lavis V, Busaidy NL. Oncologic outcomes in diabetic patients with colon cancer. Program of 89th Annual Meeting of The Endocrine Society, 2007.
10. Escobedo, J, Lavis, VR, Lombardero, M, Buitron, V, Zonszein J. Patients with type 2 diabetes suffering from cornary artery disease have better lipid and glycemic control than reported in NHANES 1999-2002, but remain undertreated: The BARI-2D Study. Program of 67th Annual Meeting of the American Diabetes Association, 2007.
11. Vu KD, Strom S, Konopleva M, Thomas D, Faderl S, Hubbard J, Andreeff M, Kantarjian H, Lavis V. . Prevalence of hyperglycemia and obesity in patients (pts) with newly diagnosed acute lymphoblastic leukemia (ALL). Program of 67th Annual Meeting of The American Diabetes Association, 2007.
12. Picolos, M.K., Lavis, V.R., and Orlander, P.;. Milk-alkali syndrome is a major cause of hypercalcemia among inpatients. Program of 86th Annual Meeting of The Endocrine Society, 2004.
13. IIiescu, Stack, A. Scott, G., Underwood, C., Fulton, S., Camarillo, C., Olivares, M., Dasher, K., Santamaria, A., Salas, J., Smalling, R., Lavis, V., and Fuentes, R.;. Association of traditional coronary risk factors with coronary artery disease among patients with diabetes; an angiographic study. program of 9th Annual Session of Society of Geriatric Cardiology, 2003.
14. Boccalandro, C., Xue, L.,Lavis, V.R., Orlander, P.R., and Milewicz, D.M.;. An Aquaporin 2 Water Channel Gene Mutation Causing Nephrogenic Diabetes Insipidus in a Mexican Family. Program of 84th Annual Meeting of the Endocrine Society:P1-707, 2002.

Book Chapters

1. Picolos, M.K., Lavis, V.R., and Willerson, J.T. Endocrine Disorders and the Heart. In: Cardiovascular Medicine, Third Edition. Ed(s) Willerson, J.T., Cohn, J.N., Wellems, H.J.J., and Holmes, D.R. Springer,: London, 2295-2330, 2007.
2. |BLavis V.R. Endocrine System. In: Heart Disease in Women. Ed(s) Wilansky, S. and Willerson, J.T. Churchill Livingstone: New York, 25-35, 2002.
3. Lavis V.R. and Willerson J.T. Endocrine Disorders and the Heart. In: Cardiovascular Medicine, Second Edition. Ed(s) Willerson, J.T. and Cohn, J.N. Churchill Livingstone: New York, 1915-1937, 2000.
4. Lavis V.R. Pheochromocytoma. In: Saunders Manual of Medical Practice. Ed(s) Rakel, R.E.,. W.B. Saunders: Philadelphia, 867-869, 1999.
5. Lavis V.R., and Fred, H.L. Hypoparathyroidism. In: Current Diagnosis 9. Ed(s) Conn, R.B., Borer, W.F., and Snyder, J.W. W.B. Saunders: Philadelphia, 770-771, 1997.
6. Lavis, V.R., Mueller, S.D. and Willerson, J.T.,. Endocrine Disorders and the Heart. In: Cardiovascular Medicine. Ed(s) Willerson, J.T. and Cohn, J.N. Churchill Livingstone: New York, 1607-1631, 1994.
7. Lavis V.R. Hypoglycemia. In: Magill's Survey of Science: Medical Science. Salem Press: Pasadena, California, 1994.
8. Thompson WJ, Lavis VR, Whalin ME, Strada SJ. Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases. In: Adv Second Messenger Phosphoprotein Res. Vol. 25. Ed(s) S.J. Strada and H.Hidaka. Raven Press: New York, 165-184, 1992. ISBN: 1313258.
9. Lavis V.R. Role of gluconeogenesis in diabetic hyperglycemia. In: Hormonal regulation of Gluconeogenesis. Vol. 1. Ed(s) Kraus-Friedmann, N.,. CRC Press: Orlando, FL., 65-76, 1986.
10. Lavis V.R. Psychiatric manifestations of endocrine disease in the elderly. In: Psychiatric Manifestations of Physical Disease in the Elderly. Ed(s) Levenson, A.J. and Hall, R.C.W. Raven Press: New York, 59-81, 1980.
11. Lavis V.R. Antidiabetic agents. In: Neuropsychiatric Side Effects of Drugs in the Elderly. Ed(s) Levenson, A.J. Raven Press: New York, 151-171, 1979.

Letters to the Editor

1. Lavis VR. Treatment of diabetic ketoacidosis. Diabetes Care 2(4)(4):385-7, Jul-Aug, 1979. PMID: 116833.

Manuals, Teaching Aids, Other Teaching Publications

1. Lavis V. Online Guide to Treatment of Diabetic Ketoacidosis in Adults;, 2006.
2. Teaching Aids on UTMSH Endocrinology website at http://www.uth.tmc.edu/schools/med/imed/endo/patientcare.htm:, 2006.
3. Lavis V. Three study cases for UTMSH second-year Problems-Based Learning course, 2006.

Last updated: 1/10/2013